A randomised phase III study on capecitabine%2525252C oxalip…
A randomised phase III study on capecitabine%2525252C oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer%2525252C the CAIRO2 study of the Dutch Colorectal Cancer Group %25252528DCCG%25252529. An interim analysis of toxicity.
Article, Chapter
Full text availability for this item
Coverage:
- 1990~present
Collection:
PubMed Central
Opens in new Window
Coverage:
- 1990~12 months ago